Australian Statistics on Medicines 2010

Table 1 - Alimentary Tract And Metabolism

ALIMENTARY TRACT AND METABOLISM

A01 - STOMATOLOGICAL PREPARATIONS
A02 - DRUGS FOR ACID RELATED DISORDERS
A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
A04 - ANTIEMETICS AND ANTINAUSEANTS
A05 - BILE AND LIVER THERAPY
A06 - LAXATIVES
A07 - ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS
A08 - ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS
A09 - DIGESTIVES INCL ENZYMES
A10 - ANTIDIABETIC THERAPY
A11 - VITAMINS
A12 - MINERAL SUPPLEMENTS
A14 - ANABOLIC AGENTS FOR SYSTEMIC USE

A01 - STOMATOLOGICAL PREPARATIONS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM STOMATOLOGICAL PREPARATIONS STOMATOLOGICAL PREPARATIONS ANTIINFECTIVES FOR LOCAL ORAL TREATMENT
A01AB04	AMPHOTERICIN
	P	2931G	Lozenge 10mg	40.00	MG	140,630	1,721,580
	P	3306B	Lozenge 10mg	40.00	MG	3,912	46,319
A01AB03	CHLORHEXIDINE
	A	21081	Mouth wash 2mg per mL (0.2%) 300mL	30.00	MG	357	—
	P	4161B	Mouth wash 2mg per mL (0.2%) 250mL	30.00	MG	539	7,212
	P	4204G	Mouth wash 2mg per mL (0.2%) 300mL	30.00	MG	1,082	17,216
A01AB09	MICONAZOLE
	A	13832	Oral gel 20mg per mL (2%) 20g	0.20	GM	2,540	—
	A	14054	Oral gel 40mg per mL (2%) 40g	0.20	GM	2,028	—
A01AB11	NYSTATIN
	P	3033P	Oral suspension 100,000 units per mL 24mL	1500.00	TE	144,182	1,585,973
	P	3343Y	Oral suspension 100,000 units per mL 24mL	1500.00	TE	870	9,424
A01AB11	POVIDINE IODINE
	A	10359	Gargle 1	—	—	207	—
CORTICOSTEROIDS FOR LOCAL ORAL TREATMENT
A01AC01	TRIAMCINOLONE ACETONIDE with PECTIN
	A	11075	Paste 1% 5gm	—	—	10,675	—
OTHER AGENTS FOR LOCAL ORAL TREATMENT
A01AD02	BENZYDAMINE HYDROCHLORIDE
	P	1121B	Mouth and throat rinse 22.5mg per 15mL 500mL	—	—	3,965	86,361
	P	5032W	Mouth and throat rinse 22.5mg per 15mL 500mL	—	—	290	6,455
	P	5385K	Mouth and throat rinse 22.5mg per 15mL 500mL	—	—	145	5,017
A01AD11	CHOLINE SALICYLATE with CETALKONIUM CHLORIDE
	A	12855	Gel 10g 1	—	—	1,268	—
A01AD11	SALIVA SUBSTITUTE
	P	4568K	Solution 25mL	—	—	369	4,011
	P	4569L	Solution 100mL	—	—	587	8,042
A01AD11	VARIOUS
	P	5334R	Spray 10mg per mL 100mL	—	—	412	5,400
	P	5336W	Spray 10mg per mL 100mL	—	—	120	1,636

A02 - DRUGS FOR ACID RELATED DISORDERS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM DRUGS FOR ACID RELATED DISORDERS ANTACIDS ALUMINIUM COMPOUNDS
A02AB01	ALUMINIUM HYDROXIDE
	A	10038	Tablet 600mg 100	—	—	1,818	—
CALCIUM COMPOUNDS
A02AC10	CALCIUM CARBONATE with GLYCINE
	P	4055K	Tablet 420mg-180mg	—	—	356	8,169
COMBS.AND COMPLEXES OF ALUMINIUM,CALCIUM AND MAGNESIUM COMPOUNDS
A02AD	ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE
	P	2157M	Oral suspension 200mg-200mg per 5mL 500mL	—	—	90,240	1,411,548
	P	4118R	Oral suspension 400mg-400mg-30mg per 5mL	—	—	2,132	47,411
A02AD	ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE with SIMETHICONE
	A	20644	Chewable tablet 200mg-200mg-20mg 100	—	—	139	—
	P	4453J	Tablet 400mg-400mg-40mg 200	—	—	1,798	80,768
A02AD	ALUMINIUM HYDROXIDE with MAGNESIUM TRISILICATE and MAGNESIUM HYDROXIDE
	P	2159P	Oral suspension 250mg-120mg-120mg per 5mL	—	—	17,278	289,511
DRUGS FOR PEPTIC ULCER AND GORD
H2-RECEPTOR ANTAGONISTS
A02BA01	CIMETIDINE
	P	1157X	Tablet 200mg	0.80	GM	1,590	31,067
	P	1158Y	Tablet 400mg	0.80	GM	15,713	308,782
	P	1159B	Tablet 800mg	0.80	GM	1,353	27,181
A02BA03	FAMOTIDINE
	P	2487X	Tablet 20mg	40.00	MG	44,044	766,060
	P	2488Y	Tablet 40mg	40.00	MG	54,018	995,036
A02BA04	NIZATIDINE
	P	1504E	Capsules 300mg 30	0.30	GM	61,163	1,193,780
	P	1505F	Capsules 150mg 30	0.30	GM	81,763	1,555,048
A02BA02	RANITIDINE HYDROCHLORIDE
	A	17165	Tablet 150mg 28	0.30	GM	186	—
	P	1937Y	Effervescent tablet 150mg (base)	0.30	GM	42,553	757,561
	P	1977C	Tablet 300mg (base)	0.30	GM	268,364	4,900,455
	P	1978D	Tablet 150mg (base)	0.30	GM	579,440	10,288,922
	P	8162N	Syrup 150mg (base) per 10mL 300mL	0.30	GM	27,837	556,213
	P	8903N	Effervescent tablet 150mg (base)	0.30	GM	1,553	34,377
	P	8905Q	Syrup 150mg (base) per 10mL 300mL	0.30	GM	952	26,628
PROSTAGLANDINS
A02BB01	MISOPROSTOL
	P	1648R	Tablet 200ug	0.80	MG	2,194	114,171
PROTON PUMP INHIBITORS
A02BC05	ESOMEPRAZOLE
	A	20665	Sachet granules 10mg 30	30.00	MG	3,038	—
	P	3401B	Tablet 40mg (enteric coated) 30	30.00	MG	6,710	434,885
	P	8600P	Tablet 20mg (enteric coated) 30	30.00	MG	3,865,457	133,441,756

A02 - DRUGS FOR ACID RELATED DISORDERS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM DRUGS FOR ACID RELATED DISORDERS DRUGS FOR PEPTIC ULCER AND GORD
	P	8601Q	Tablet 40mg (enteric coated) 30	30.00	MG	2,519,521	132,209,143
	P	8886Q	Tablet 20mg (enteric coated) 30	30.00	MG	123,985	4,264,200
A02BC03	LANSOPRAZOLE
	P	2240X	Capsule 30mg 28	30.00	MG	2,038	61,789
	P	2241Y	Capsule 30mg 28	30.00	MG	57,466	1,746,987
	P	8198L	Capsule 15mg 28	30.00	MG	15,685	361,301
	P	9331D	Capsule 15mg 28	30.00	MG	7,557	148,778
	P	9477T	Tablet 30mg (orally disintegrating) 28	30.00	MG	15,121	472,408
	P	9478W	Tablet 30mg (orally disintegrating) 28	30.00	MG	499,090	17,124,914
A02BC01	OMEPRAZOLE
	P	1326T	Capsule 20mg	20.00	MG	7,392	213,180
	P	1327W	Capsule 20mg	20.00	MG	192,582	6,656,307
	P	8331L	Tablet 20mg (as magnesium salt) 30	20.00	MG	38,764	1,022,342
	P	8332M	Tablet 10mg (as magnesium salt) 30	20.00	MG	72,411	1,695,940
	P	8333N	Tablet 20mg (as magnesium salt) 30	20.00	MG	914,936	27,368,559
	P	9109K	Tablet 20mg (as magnesium salt) 30	20.00	MG	41,937	1,229,990
	P	9110L	Tablet 20mg (as magnesium salt) 30	20.00	MG	1,906,325	67,890,050
A02BC02	PANTOPRAZOLE
	A	20488	Tablet (enteric coated) equivalent to 20mg 7	40.00	MG	864	—
	A	20489	Tablet (enteric coated) equivalent to 20mg 14	40.00	MG	1,255	—
	P	8007K	Tablet (enteric coated) equivalent to 40mg	40.00	MG	371,240	12,302,789
	P	8008L	Tablet (enteric coated) equivalent to 40mg	40.00	MG	3,407,316	123,495,663
	P	8399C	Tablet (enteric coated) equivalent to 20mg	40.00	MG	474,221	9,447,805
	P	9423Y	Sachet containing granules 40mg 30	40.00	MG	3,548	120,618
	P	9424B	Sachet containing granules 40mg 30	40.00	MG	23,725	824,903
A02BC04	RABEPRAZOLE
	P	8507R	Tablet 10mg 30	20.00	MG	72,719	2,777,341
	P	8508T	Tablet 20mg 30	20.00	MG	2,182,303	89,636,491
	P	8509W	Tablet 20mg 30	20.00	MG	231,551	8,731,413
COMBINATIONS FOR ERADICATION OF HELICOBACTER PYLORI
A02BD06	ESOMEPRAZOLE AMOXICILAN and CLARITHROMYCIN
	P	8738X	Pack 14 tabs(ent coated)equiv 20mg esomeprazole	—	—	77,755	6,323,242
A02BD05	OMEPRAZOLE and CLARITHROMYCIN and AMOXYCILLIN
	P	8272J	Pack 14 caps 20mg,14 tabs 500mg,28 caps 500mg	—	—	13,531	991,395
OTHER DRUGS FOR PEPTIC ULCER AND GORD
A02BX13	SODIUM ALGINATE with CALCIUM CARBONATE and SODIUM BICARBONATE
	P	2014B	Oral liquid 1gm-320mg in 20mL 500mL	—	—	111,649	1,636,639
A02BX02	SUCRALFATE
	P	2055E	Tablet 1g	4.00	GM	15,651	372,544
ANTIFLATULENTS
ANTIFLATULENTS
A02DA	PEPPERMINT OIL
	A	13210	Capsule 0.2mL 63	—	—	129	—

A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS DRUGS FOR FUNCTIONAL BOWEL DISORDERS SYNT ANTICHOLIN,ESTERS WITH TERTIARY AMINO GROUP
A03AA04	MEBEVERINE HYDROCHLORIDE
	A	12730	Tablet 135mg 30	0.30	GM	13,687	—
	A	14130	Tablet 135mg 30	0.30	GM	10,352	—
	P	4328T	Tablet 135mg	0.30	GM	60,671	1,805,003
SYNT ANTICHOLINERGICS,ESTERS,QUATER AMMONIUM COMPOUND
A03AB05	PROPANTHELINE
	P	1953T	Tablet 15mg	60.00	MG	17,897	455,916
OTHER DRUGS FOR FUNCTIONAL BOWEL DISORDERS
A03AX13	SIMETHICONE
	A	13445	Capsule 100mg 30	—	—	230	—
BELLADONNA AND DERIVATIVES PLAIN
BELLADONNA ALKALOIDS TERTIARY AMINES
A03BA01	ATROPINE
	P	1089H	Injection 600ug in 1mL 10	1.50	MG	2,752	58,237
	P	3453R	Injection 600ug in 1mL 10	1.50	MG	10,315	209,575
BELLADONNA ALKALOIDS SEMISYNT QUATER AMMONIUM COMPOUND
A03BB01	BUTYLSCOPOLAMINE
	A	12939	Tablet 10mg 100	60.00	MG	11,218	—
	A	15287	Tablet 10mg	60.00	MG	9,028	—
	P	3473T	Injection 20mg in 1mL 5	60.00	MG	6,337	151,310
	P	4279F	Injection 20mg in 1mL	60.00	MG	3,807	133,004
	P	5317W	Injection 20mg in 1mL	60.00	MG	2,592	247,436
	P	5318X	Injection 20mg in 1mL	60.00	MG	446	59,616
A03BB	HYOSCINE HYDROBROMIDE
	A	10972	Ampoule 400ug 5	—	—	4,748	—
PROPULSIVES
PROPULSIVES
A03FA03	DOMPERIDONE
	A	11309	Tablet 10mg 100	30.00	MG	15,488	—
	P	1347X	Tablet 10mg	30.00	MG	321,156	4,078,502
A03FA01	METOCLOPRAMIDE HYDROCHLORIDE
	A	11138	Tablet 10mg 100	30.00	MG	2,363	—
	P	1206L	Injection 10mg in 2mL	30.00	MG	41,487	621,319
	P	1207M	Tablet 10mg	30.00	MG	790,929	6,828,914
	P	3476Y	Injection 10mg in 2mL	30.00	MG	28,914	375,052
	P	5151D	Tablet 10mg	30.00	MG	239	1,956

A04 - ANTIEMETICS AND ANTINAUSEANTS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS SEROTONIN (5HT3) ANTAGONISTS
A04AA04	DOLASETRON MESYLATE
	P	5923R	Tablet 200mg	0.20	GM	242	14,031
	P	5924T	I.V. injection 100mg in 5mL	0.10	GM	558	10,323
	P	8191D	Tablet 200mg	0.20	GM	10,566	592,942
	P	8192E	I.V. injection 100mg in 5mL	0.10	GM	4,396	150,834
A04AA02	GRANISETRON
	P	5898K	Tablet 2mg (base) 2	2.00	MG	10,001	545,123
	P	5899L	Concentrated injection 3mg (base) in 3mL	3.00	MG	11,569	312,623
	P	8728J	Tablet 2mg (base) 2	2.00	MG	48,459	3,157,333
	P	8729K	Concentrated injection 3mg (base) in 3mL	3.00	MG	52,276	2,225,455
	P	8873B	Tablet 2mg (base) 5	2.00	MG	711	197,411
A04AA01	ONDANSETRON
	P	1594X	Tablet 4mg	16.00	MG	3,785	487,204
	P	1595Y	Tablet 8mg	16.00	MG	4,215	767,521
	P	5967C	Tablet 4mg	16.00	MG	828	26,696
	P	5968D	Tablet 8mg	16.00	MG	15,299	705,750
	P	5969E	Wafer 4mg 4	16.00	MG	150	7,397
	P	5970F	Wafer 8mg 4	16.00	MG	1,451	86,628
	P	5971G	I.V. injection 4mg in 2mL	16.00	MG	119	1,638
	P	5972H	I.V. injection 8mg in 4mL	16.00	MG	13,280	259,471
	P	8224W	Tablet 4mg	16.00	MG	13,695	631,495
	P	8225X	Tablet 8mg	16.00	MG	55,554	3,583,483
	P	8226Y	I.V. injection 4mg in 2mL	16.00	MG	2,936	66,580
	P	8227B	I.V. injection 8mg in 4mL	16.00	MG	20,421	803,249
	P	8410P	Wafer 4mg 4	16.00	MG	27,072	1,225,316
	P	8411Q	Wafer 8mg 4	16.00	MG	23,548	1,774,603
	P	8412R	Wafer 4mg 10	16.00	MG	9,478	1,173,422
	P	8413T	Wafer 8mg 10	16.00	MG	8,041	1,530,771
	P	9441X	Syrup 4mg per 5mL 50mL 1	16.00	MG	382	40,598
A04AA05	PALONOSETRON
	P	5295Q	Injection 250ug (as hydrochloride) in 5mL 1	0.25	MG	1,978	93,399
A04AA03	TROPISETRON
	P	2745L	Capsule 5mg (base)	5.00	MG	21,410	1,247,215
	P	2746M	I.V. injection 5mg/5mL	5.00	MG	11,640	393,738
	P	5986C	Capsule 5mg (base)	5.00	MG	6,109	209,144
	P	5987D	I.V. injection 5mg/5mL	5.00	MG	4,625	86,044
VARIOUS ANTIEMETICS
A04AD12	APREPITANT
	P	5888X	Pack 1 cap 125mg and 2 cap 80mg	95.00	MG	10,045	1,168,735
	P	8808N	Pack 1 cap 125mg and 2 cap 80mg	95.00	MG	28,352	4,065,237
A04AD01	SCOPOLAMINE
	A	20612	Tablet 20mg 10	60.00	MG	766	—

A05 - BILE AND LIVER THERAPY
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM BILE AND LIVER THERAPY BILE THERAPY BILE ACID PREPARATIONS
A05AA02	URSODEOXYCHOLIC ACID
	P	8448P	Capsule 250mg 200	0.75	GM	26,881	9,255,033

A06 - LAXATIVES
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM LAXATIVES LAXATIVES SOFTENERS EMOLLIENTS
A06AA02	DOCUSATE SODIUM
	A	16099	Tablet 120mg 100	0.15	GM	9,030	—
	P	4200C	Tablet 50mg	0.15	GM	9,048	129,811
A06AA01	LIQUID PARAFFIN
	A	10108	Oral suspension vanilla 500mL	15.00	GM	1,401	—
	A	10120	Oral suspension strawberry 500mL	15.00	GM	136	—
A06AA	POLOXALKOL
	A	10469	Drop 10% 30mL 1	—	—	125	—
CONTACT LAXATIVES
A06AB02	BISACODYL
	P	1258F	Suppositories 10mg 12	10.00	MG	2,977	54,290
	P	1259G	Tablet 5mg	10.00	MG	26,817	381,665
	P	1260H	Suppositories 10mg 10	10.00	MG	33,413	693,809
	A	12669	Tablet 5mg 50	10.00	MG	220	—
	P	3250C	Suppositories 10mg 10	10.00	MG	483	19,913
	P	5303D	Suppositories 10mg 10	10.00	MG	195	4,727
A06AB56	DOCUSATE SODIUM with SENNA
	A	12753	Tablet 30	—	—	4,249	—
	P	4028B	Tablet 50mg-8mg 100	—	—	14,390	212,394
	P	4198Y	Tablet 50mg-8mg 90	—	—	241,168	3,952,419
A06AB06	SENNA STANDARDISED
	P	4455L	Tablet 7.5mg	—	—	9,778	135,982
BULK PRODUCERS
A06AC51	ISPAGHULA COMBINATIONS
	P	4416K	Oral Powder 440g	—	—	609	12,926
A06AC01	PSYLLIUM HYDROPHILIC MUCILLOID
	A	11156	Powder 500g 1	7.00	GM	564	—
	A	11273	Powder 500g 1	7.00	GM	115	—
	P	4285M	Sachets 3.5g 30	7.00	GM	2,104	42,461
	P	4419N	Oral powder(orange-flavour sugar free)315g	7.00	GM	22,105	495,566
	P	4422R	Oral powder (non-flavoured) 375g	7.00	GM	13,706	305,707
A06AC53	STERCULIA with FRANGULA BARK
	P	1104D	Granules 620mg-80mg per g (62%-8%) 500g	—	—	73,718	1,850,564
	P	3275J	Granules 620mg-80mg per g (62%-8%) 500g	—	—	832	26,888
	P	4558X	Granules 620mg-80mg per g (62%-8%) 500g	—	—	6,526	164,376
A06AC53	STERCULIA, COMBINATIONS
	P	5322D	Granules 620mg-80mg per g (62%-8%) 500g	—	—	358	12,224
OSMOTICALLY ACTING LAXATIVES
A06AD11	LACTULOSE
	P	3064G	Mixture 3.34g per 5mL 500mL	6.70	GM	344,367	4,900,389
	P	5387M	Mixture 3.34g per 5mL 500mL 1	6.70	GM	8,788	179,530
	P	5388N	Mixture 3.34g per 5mL 500mL 1	6.70	GM	243	5,415

A06 - LAXATIVES
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM LAXATIVES LAXATIVES
A06AD11	LACTULOSE with GALACTOSE with LACTOSE with EPILACTOSE
	A	10693	Syrup 200mL 1	6.70	GM	330	—
A06AD15	MACROGOL
	A	20664	Sachets powder 100g with electrolytes 4	10.00	GM	191	—
	P	3278M	Sachets powder 13.125g with electrolytes 2	10.00	GM	1,111	29,202
	P	3416T	Powder for oral solution 510g	10.00	GM	3,259	71,341
	P	5389P	Sachets powder 13.125g with electrolytes 30	10.00	GM	5,516	221,172
	P	5390Q	Sachets powder 13.125g with electrolytes 30	10.00	GM	447	18,629
	P	8612G	Sachets powder 13.125g with electrolytes 30	10.00	GM	737,802	17,571,866
	P	9146J	Sachets powder 6.563g with electrolytes 30	10.00	GM	25,319	473,173
A06AD	SORBITOL
	A	14787	Liquid 70% 500mL	—	—	5,664	—
ENEMAS
A06AG02	BISACODYL
	P	1263L	Enemas 10mg in 5mL 25	—	—	9,618	413,865
	P	3263R	Enemas 10mg in 5mL 25	—	—	3,250	184,448
	P	5302C	Enemas 10mg in 5mL 25	10.00	MG	357	24,908
A06AG20	COMBINATION (SORBITOL/SODIUM CITRATE/SODIUM LAURYL SULFOACETATE)
	P	2091C	Enemas 3.125g-450mg-45mg in 5mL 12	—	—	45,322	1,576,519
	P	3274H	Enemas 3.125g-450mg-45mg in 5mL 12	—	—	4,042	201,419
	P	4462W	Enemas 3.125g-450mg-45mg in 5mL 4	—	—	2,490	30,409
	P	5331N	Enemas 3.125g-450mg-45mg in 5mL 12	—	—	1,136	58,308
A06AG01	SODIUM PHOSPHATE
	A	15629	Laxative Mixt 3.3G/5mL	—	—	828	—
PERIPHEROL OPIOID RECEPTOR ANTAGONISTS
A06AH01	METHYLNALTREXONE BROMIDE
	P	5423K	Solution for injection 12mg in 0.6mL 7	6.00	MG	229	34,419
OTHER LAXATIVES
A06AX01	GLYCEROL
	P	2555L	Suppositories 700mg (for infants) 12	—	—	453	7,597
	P	2556M	Suppositories 1.4g (for children) 12	—	—	716	12,886
	P	2557N	Suppositories 2.8g (for adults) 12	—	—	8,808	162,292
	P	3267Y	Suppositories 2.8g (for adults) 12	—	—	229	6,999
	P	4246L	Suppositories 2.8g (for adults) 12	—	—	273	5,013

A07 - ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS INTESTINAL ANTIINFECTIVES ANTIBIOTICS
A07AA01	NEOMYCIN SULPHATE
	P	2325J	Tablet 500mg	5.00	GM	971	22,095
A07AA02	NYSTATIN
	P	1696G	Tablet 500,000 units	1500.00	TE	18,274	365,723
	P	1699K	Capsule 500,000 units	1500.00	TE	33,766	753,743
A07AA09	VANCOMYCIN
	P	3113W	Capsule 125 mg (125,000 i.u.) vancomycin activity	2.00	GM	366	103,971
	P	3114X	Capsule 250 mg (250,000 i.u.) vancomycin activity	2.00	GM	648	375,588
ELECTROLYTES WITH CARBOHYDRATES
ORAL REHYDRATION SALT FORMULATIONS
A07CA	ELECTROLYTE REPLACEMENT (ORAL)
	P	3196F	Sachets of powder for oral solution 4.87g 10	—	—	22,536	364,207
ANTIPROPULSIVES
ANTIPROPULSIVES
A07DA01	DIPHENOXYLATE HYDROCHLORIDE with ATROPINE SULPHATE
	A	11123	Tablet 2.5mg-25ug 100	15.00	MG	483	—
	A	16260	Tablet 2.5mg-25ug 8	15.00	MG	2,008	—
	P	2501P	Tablet 2.5mg-25ug	15.00	MG	236,183	2,404,307
A07DA03	LOPERAMIDE HYDROCHLORIDE
	P	1571Q	Capsule 2mg	10.00	MG	255,887	4,158,733
	A	16133	Tablet 2mg 8	10.00	MG	182	—
INTESTINAL ANTIINFLAMMATORY AGENTS
CORTICOSTEROIDS FOR LOCAL USE
A07EA02	HYDROCORTISONE ACETATE
	P	1502C	Rectal foam 125mg per applicator (10%) aerosol	—	—	11,558	445,540
A07EA01	PREDNISOLONE SODIUM PHOSPHATE
	P	1920C	Retention enema equivalent to 20mg prednisolone	—	—	5,526	1,198,343
	P	2554K	Suppositories equivalent to 5mg prednisolone 10	—	—	7,604	315,077
AMINOSALICYLIC ACID AND SIMILAR AGENTS
A07EC04	BALSALAZIDE
	P	8845M	Capsule 750mg	6.75	GM	22,858	3,229,770
A07EC02	MESALAZINE
	P	1611T	Tablet 250mg	1.50	GM	57,636	9,266,883
	P	2214M	Tablet 500mg (prolonged release) 200	1.50	GM	7,731	2,182,818
	P	2234N	Oral granules (prolonged release) 1g per sachet 100	1.50	GM	2,397	679,706
	P	2287J	Oral granules (prolonged release) 2g per sachet 60	1.50	GM	12,131	3,820,516
	P	3413P	Tablet 1g (prolonged release) 120	1.50	GM	990	316,738
	P	8598M	Oral granules 500mg per sachet 100	1.50	GM	2,322	585,097
	P	8599N	Oral granules 1 mg per sachet 100	1.50	GM	19,720	5,854,585
	P	8616L	Enemas 2g in 60mL 7	1.50	GM	2,469	820,900
	P	8617M	Enemas 4g in 60mL 7	1.50	GM	7,271	3,224,247
	P	8731M	Tablet 500mg (enteric coated)	1.50	GM	53,878	15,588,102

A07 - ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS INTESTINAL ANTIINFLAMMATORY AGENTS
	P	8752P	Suppository 1g 28	1.50	GM	9,660	1,225,775
	P	8753Q	Enemas 1g in 100mL 7	1.50	GM	1,020	336,504
	P	8768L	Rectal foam 1g per app, 14 apps aerosol 80g 4	1.50	GM	1,688	555,481
	P	9206M	Sachet containing granules 1.5g per sachet	1.50	GM	6,147	1,535,126
	P	9353G	Tablet 1.2g (prolonged release) 60	1.50	GM	1,185	292,753
A07EC03	OLSALAZINE SODIUM
	P	1728Y	Capsule 250mg	1.00	GM	4,974	413,571
	P	8086N	Capsule 500mg	1.00	GM	13,683	1,777,058
A07EC01	SULPHASALAZINE
	P	2093E	Tablet 500mg	2.00	GM	25,295	1,292,539
	P	2096H	Tablet 500mg (enteric coated)	2.00	GM	194,360	10,820,695
	P	9208P	Tablet 500mg 200	2.00	GM	913	46,630
	P	9209Q	Tablet 500mg (enteric coated) 200	2.00	GM	5,556	308,163

A08 - ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS CENTRALLY ACTING ANTIOBESITY PRODUCTS
A08AA01	PHENTERMINE
	A	10636	Capsule 15mg 30	15.00	MG	18,461	—
	A	10637	Capsule 30mg 30	15.00	MG	85,670	—
	A	10638	Capsule 40mg 30	15.00	MG	70,949	—
	A	20783	Capsule 15mg 30	15.00	MG	179	—
	A	20784	Capsule 30mg 30	15.00	MG	16,818	—
	A	20785	Capsule 40mg 30	15.00	MG	15,193	—
A08AA10	SIBUTRAMINE
	A	17447	Capsule 10mg 30	10.00	MG	25,464	—
	A	17448	Capsule 15mg 30	10.00	MG	51,810	—
	A	20448	Capsule 10mg 30	10.00	MG	290	—
	A	20449	Capsule 15mg 30	10.00	MG	2,920	—
PERIPHERALLY ACTING ANTIOBESITY PRODUCTS
A08AB01	ORLISTAT
	A	18494	Capsule 120mg 84	0.36	GM	620	—
	P	4570M	Capsule 120mg 84	0.36	GM	2,454	329,036

A09 - DIGESTIVES INCL ENZYMES
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM DIGESTIVES INCL ENZYMES DIGESTIVES INCL ENZYMES ENZYME PREPARATIONS
A09AA02	PANCREATIC EXTRACT
	P	8020D	Capsule (containing enteric coated microspheres) provided not less than 10,000 BP units of lipase activity	—	—	19,030	3,169,562
	P	8021E	Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity	—	—	32,386	5,150,920
	P	8556H	Capsule (containing enteric coated microspheres) provided not less than 5,000 BP units of lipase activity	—	—	11,043	1,275,476
	P	9225M	Capsule (containing enteric coated microspheres) provided not less than 5,000 BP units of lipase activity	—	—	1,071	121,745
	P	9226N	Capsule (containing enteric coated microspheres) provided not less than 10,000 BP units of lipase activity	—	—	3,326	524,418
	P	9227P	Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity	—	—	4,942	666,716
	P	9229R	Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity	—	—	306	47,785
	P	9412J	Capsule (containing enteric coated microspheres) provided not less than 40000 BP units of lipase activity 200	—	—	3,951	921,161
	P	9413K	Capsule (containing enteric coated microspheres) provided not less than 40000 BP units of lipase activity 200	—	—	734	158,407
A09AA02	PANCRELIPASE
	P	8366H	Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity	—	—	2,787	394,240

A10 - ANTIDIABETIC THERAPY
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM ANTIDIABETIC THERAPY INSULINS AND ANALOGUES INSULINS AND ANALOGUES FAST-ACTING
A10AB02	INSULIN (BEEF)
	P	1713E	Injection 100 units per mL 10mL	40.00	IE	371	63,488
A10AB01	INSULIN (HUMAN)
	P	1531N	Injection 100 units per mL 10mL	40.00	IE	9,891	1,264,994
	P	1762R	Injection 100 units per mL 3mL 5	40.00	IE	20,615	4,455,338
A10AB05	INSULIN ASPART
	P	8435Y	Injection (human) 100 units per mL 3mL 5	40.00	IE	156,681	40,508,000
	P	8571D	Injection (human) 100 units per mL 10mL 5	40.00	IE	12,358	1,942,123
A10AB06	INSULIN GLULISINE
	P	1921D	Injection (human) 100 units per mL 3mL 5	40.00	IE	11,841	3,096,805
	P	9224L	Injection (human) 100 units per mL 10mL 5	40.00	IE	187	29,606
A10AB04	INSULIN LISPRO
	P	8084L	Injection 100 units per mL 10mL	40.00	IE	6,968	1,109,753
	P	8212F	Injection 100 units per mL 3mL 5	40.00	IE	33,737	8,840,917
INSULINS AND ANALOGUES INTERMEDIATE-ACTING
A10AC02	INSULIN (BEEF)
	P	1711C	Injection 100 units per mL 10mL	40.00	IE	674	115,177
A10AC01	INSULIN (HUMAN)
	P	1533Q	Injection 100 units per mL 10mL	40.00	IE	15,868	2,116,285
	P	1761Q	Injection 100 units per mL 3mL 5	40.00	IE	43,164	9,360,888
INSULINS AND ANALOGUES INTERMEDIATE ACTING COMBINED WITH FAST-ACTING
A10AD01	INSULIN (HUMAN)
	P	1426C	Injection 100 units per ml (30 units-70 units)	40.00	IE	1,667	225,029
	P	1763T	Injection 100 units per mL (30 units-70 units)	40.00	IE	85,697	18,968,231
	P	2062M	Injection 100 units per mL (50 units-50 units)	40.00	IE	4,245	940,377
A10AD30	INSULIN ASPART/PROTAMINE ASPART
	P	8609D	Injection (human analogue) 30/70 units per mL	40.00	IE	140,566	36,655,590
A10AD04	INSULIN LISPRO
	P	8390N	Injection (human analogue) 100 units per mL 3mL 5	40.00	IE	17,025	4,469,266
	P	8874C	Inj (human analogue) 100 units(50/50)per mL 3mL 5	40.00	IE	4,294	1,129,594
INSULINS AND ANALOGUES LONG-ACTING
A10AE05	INSULIN DETEMIR
	P	9040T	Injection 100 units per mL 3mL 5	40.00	IE	33,416	14,316,611
A10AE04	INSULIN GLARGINE
	A	18353	Injection 100 units per mL 10mL	40.00	IE	244	—
	P	9039R	Injection 100 units per mL 3mL 5	40.00	IE	225,057	95,643,199
ORAL BLOOD GLUCOSE LOWERING DRUGS
BIGUANIDES
A10BA02	METFORMIN HYDROCHLORIDE
	P	1801T	Tablet 850mg	2.00	GM	340,231	4,567,330
	A	21261	Tablet 500mg (extended release) 90	2.00	GM	805	—
	A	21262	Tablet 500mg (extended release) 90	2.00	GM	320	—

A10 - ANTIDIABETIC THERAPY
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM ANTIDIABETIC THERAPY ORAL BLOOD GLUCOSE LOWERING DRUGS
	P	2430X	Tablet 500mg	2.00	GM	1,433,376	18,752,573
	P	3439B	Tablet 1g (extended release) 60	2.00	GM	34,079	579,619
	P	8607B	Tablet 1000mg	2.00	GM	1,251,853	22,451,012
	P	8884N	Tablet 500mg (extended release) 90	2.00	GM	533,943	7,711,518
	P	9435N	Tablet 500mg (extended release) 120	2.00	GM	938,816	15,720,809
SULFONAMIDES UREA DERIVATIVES
A10BB01	GLIBENCLAMIDE
	P	2939Q	Tablet 5mg	10.00	MG	100,353	1,160,957
A10BB09	GLICLAZIDE
	P	2449X	Tablet 80mg 100	60.00	MG	323,020	4,362,807
	P	8535F	Tablet 30mg (modified release) 100	60.00	MG	966,773	13,219,399
	P	9302N	Tablet 60mg (modified release) 60	60.00	MG	548,301	8,263,574
A10BB12	GLIMEPIRIDE
	P	8450R	Tablet 1mg 30	2.00	MG	61,881	563,960
	P	8451T	Tablet 2mg 30	2.00	MG	84,971	981,771
	P	8452W	Tablet 4mg 30	2.00	MG	227,295	3,329,353
	P	8533D	Tablet 3mg 30	2.00	MG	33,310	434,144
A10BB07	GLIPIZIDE
	P	2440K	Tablet 5mg 100	10.00	MG	63,660	767,044
BIGUANIDES AND SULFONAMIDES IN COMBINATION
A10BD02	METFORMIN and SULFONAMIDES
	P	8811R	Tablet 500mg-5mg 90	—	—	80,491	1,377,449
	P	8838E	Tablet 250mg-1.25 90	—	—	4,024	54,013
A10BD02	METFORMIN with GLIBENCLAMIDE
	P	8810Q	Tablet 500mg-2.5mg 90	—	—	41,654	658,134
A10BD03	ROSIGLITAZONE with METFORMIN
	P	9059T	Tablet 2mg(base)-500mg 56	—	—	5,854	386,092
	P	9060W	Tablet 2mg(base)-1000mg 56	—	—	16,303	1,122,622
	P	9061X	Tablet 4mg(base)-500mg 56	—	—	5,825	555,220
	P	9062Y	Tablet 4mg(base)-1000mg 56	—	—	30,358	2,981,414
A10BD07	SITAGLIPTIN with METFORMIN
	P	9449H	Tablet 50mg (as phosphate monohydrate) - 500mg 56	—	—	22,088	2,095,915
	P	9450J	Tablet 50mg (as phosphate monohydrate) - 850mg 56	—	—	14,115	1,373,910
	P	9451K	Tablet 50mg (as phosphate monohydrate) - 1000mg 56	—	—	79,689	7,799,274
ALPHA GLUCOSIDASE INHIBITORS
A10BF01	ACARBOSE
	P	8188Y	Tablet 50mg	0.30	GM	26,294	816,135
	P	8189B	Tablet 100mg	0.30	GM	24,494	1,030,663
THIAZOLIDINEDIONES
A10BG03	PIOGLITAZONE HYDROCHLORIDE
	P	8694N	Tablet 15mg (base) 28	30.00	MG	95,390	5,887,498
	P	8695P	Tablet 30mg (base) 28	30.00	MG	252,244	23,029,676
	P	8696Q	Tablet 45mg (base) 28	30.00	MG	147,280	17,181,208

A10 - ANTIDIABETIC THERAPY
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM ANTIDIABETIC THERAPY ORAL BLOOD GLUCOSE LOWERING DRUGS
A10BG02	ROSIGLITAZONE
	P	8689H	Tablet 4mg (base) 28	6.00	MG	39,493	2,489,338
	P	8690J	Tablet 8mg (base) 28	6.00	MG	40,600	3,728,845
DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS
A10BH01	SITAGLIPTIN
	P	9180E	Tablet 25mg (as phosphate monohydrate) 28	0.10	GM	17,005	1,568,179
	P	9181F	Tablet 50mg (as phosphate monohydrate) 28	0.10	GM	45,861	4,222,298
	P	9182G	Tablet 100mg (as phosphate monohydrate) 28	0.10	GM	234,126	21,377,255
A10BH02	VILDAGLIPTIN
	P	3415R	Tablet 50mg 60	0.10	GM	12,968	1,258,561
OTHER BLOOD GLUCOSE LOWERING DRUGS
A10BX04	EXENATIDE
	A	20214	Soln for inj 10ug per 40mL 2.4mL cartridge	0.02	MG	1,249	—
	P	3423E	Injection solution 5ug per dose in pre-filled pen 60 doses 1	0.02	MG	3,380	594,678
	P	3424F	Injection solution 10ug per dose in pre-filled pen 60 doses 1	0.02	MG	6,186	1,063,818
A10BX02	REPAGLINIDE
	A	16646	Tablet 1mg 90	6.00	MG	227	—
	A	16647	Tablet 2mg 90	6.00	MG	153	—

A11 - VITAMINS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM VITAMINS VITAMIN A AND D INCL COMBINATIONS OF THE TWO VITAMIN A PLAIN
A11CA01	VITAMIN A
	A	12182	Capsule 50 000 units 100	50.00	TE	265	—
VITAMIN D AND ANALOGUES
A11CC04	CALCITRIOL
	P	2502Q	Capsule 0.25ug	1.00	UG	152,400	6,706,909
A11CC01	ERGOCALCIFEROL
	A	16060	Capsule 25ug 60	—	—	824,122	—
VITAMIN B1,PLAIN AND IN COMB. WITH VITAMIN B6 AND B12
THIAMINE (VITAMIN B1) PLAIN
A11DA01	THIAMINE HYDROCHLORIDE
	P	1070H	Tablet 100mg	50.00	MG	29,665	320,666
	P	4043T	Tablet 100mg	50.00	MG	28,806	311,131
VITAMIN B-COMPLEX INCL COMBINATIONS
VITAMIN B-COMPLEX PLAIN
A11EA	VITAMIN B GROUP COMPLEX
	P	4493L	Oral liquid 200mL	—	—	11,051	148,107
OTHER PLAIN VITAMIN PREPARATIONS
OTHER PLAIN VITAMIN PREPARATIONS
A11HA02	PYRIDOXINE HYDROCHLORIDE
	A	11648	Tablet 25mg 100	160.00	MG	1,543	—
	A	11649	Tablet 100mg 50	160.00	MG	1,075	—
OTHER VITAMIN PRODUCTS COMBINATIONS
VITAMINS WITH MINERALS
A11JB	VITAMINS with MINERALS
	A	10099	Capsule 30	—	—	1,815	—
	A	12947	Capsule 100	—	—	282	—

A12 - MINERAL SUPPLEMENTS
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM MINERAL SUPPLEMENTS CALCIUM CALCIUM
A12AA04	CALCIUM CARBONATE
	A	20271	Tablet 600mg (as carbonate) 120	3.00	GM	57,154	—
	P	3116B	Tablet (chewable) 500mg (as carbonate)	3.00	GM	15,087	413,034
	P	3117C	Tablet 600mg (as carbonate) 240	3.00	GM	1,581	28,882
	P	4082W	Tablet (chewable) 600mg (as carbonate) 120	3.00	GM	6,621	94,022
	P	4094L	Tablet (chewable) 500mg (as carbonate)	3.00	GM	2,131	59,102
	P	4142B	Tablet 600mg (as carbonate) 240	3.00	GM	1,032	21,936
	P	4333C	Tablet (chewable) 500mg (as carbonate) 120	3.00	GM	6,552	117,288
A12AA	CALCIUM CITRATE
	P	4093K	Tablet 250mg (as citrate) 240	—	—	271	5,480
	P	4332B	Tablet 250mg (as citrate) 120	—	—	5,765	40,841
CALCIUM, COMBINATIONS WITH OTHER DRUGS
A12AX	CALCIUM CARBONATE with CHOLECALCIFEROL
A	10600	Tablet 600mg 60	3.00	— 11,698	—
POTASSIUM
POTASSIUM
A12BA01	POTASSIUM CHLORIDE
	P	2642C	Tablet 600mg (sustained release)	3.00	GM	298,749	3,830,063
	P	3012M	Effervescent tabs 14mmol K,8mmol Cl ions	3.00	GM	30,090	484,918
OTHER MINERAL SUPPLEMENTS
ZINC
A12CB01	ZINC SULPHATE
	A	12264	Capsule 50mg 100	0.60	GM	371	—
MAGNESIUM
A12CC05	MAGNESIUM ASPARTATE
	A	11226	Tablet 100	—	—	2,691	—
	P	4321K	Tablet 37.4mg (as aspartate dihydrate)	—	—	50,059	817,565

A14 - ANABOLIC AGENTS FOR SYSTEMIC USE
				2010
ATC	ITEM TYPE	CODE	FORM AND STRENGTH	DDD	UNITS	SCRIPTS	COST($)
ALIMENTARY TRACT AND METABOLISM ANABOLIC AGENTS FOR SYSTEMIC USE ANABOLIC STEROIDS ESTREN DERIVATIVES
A14AB01	NANDROLONE DECANOATE
	P	1671Y	Injection 50mg in 1mL disposable syringe	2.00	MG	10,794	239,852

Australian Statistics on Medicines 2010

Table 1 - Alimentary Tract And Metabolism

Department of Health and Aged Care

Pharmaceutical Benefits Scheme

PBS Information

Browse the PBS

For Health Professionals

For Industry